Review
Screening for Infectious Diseases Among Substance Abusers
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993. Report No.: (SMA) 95-3060.
- PMID: 22514863
- Bookshelf ID: NBK64727
Item in Clipboard
Review
Screening for Infectious Diseases Among Substance Abusers
Excerpt
This TIP focuses on infectious diseases that are prevalent in and especially harmful to patients in drug treatment, and that can be medically managed by treatment staff or through referrals for primary care. The treatment recommendations in this TIP are largely, but not exclusively, based on guidelines from the Centers for Disease Control and Prevention (CDC). Trained medical staff are needed to diagnose and treat these diseases. Treatment providers who do not offer such medical resources are encouraged to refer their patients to community-based health care professionals. Followup care of those patients referred initially to other health care professionals should be provided.
Sections
- What Is a TIP?
- Consensus Panel Members
- Foreword
- Definition of the Term "Drug Use"
- Chapter 1 - Introduction
- Chapter 2 - Issues for Counselors
- Chapter 3 - Legal and Ethical Issues
- Chapter 4 - Issues for Treatment Program Administrators: Staff and Community Development and Environmental Safety
- Chapter 5 - The Initial Patient Contact
- Chapter 6 - Summary Statement on Tuberculosis
- Chapter 7 - Tuberculosis
- Chapter 8 - Multidrug-Resistant Tuberculosis
- Chapter 9 - Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome
- Chapter 10 - Syphilis
- Chapter 11 - Introduction to Viral Hepatitis
- Chapter 12 - Viral Hepatitis B
- Chapter 13 - Viral Hepatitis C
- Chapter 14 - Viral Hepatitis A
- Chapter 15 - Viral Hepatitis D
- Chapter 16 - Gonorrhea
- Chapter 17 - Chlamydia
- Chapter 18 - Herpes Simplex
- Chapter 19 - Chancroid
- Appendix A - Bibliography
- Appendix B - Federal Resource Panel on Screening for Infectious Diseases Among Substance Abusers
- Appendix C - TIP Field Reviewers
- Appendix D - Resource List
- Appendix E - Program Models and Sample Budgets
- Appendix F - Quality Assurance
- Appendix G - HIV/AIDS Prevention Bulletin
Similar articles
-
Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.MMWR Recomm Rep. 2012 Nov 9;61(RR-5):1-40. MMWR Recomm Rep. 2012. PMID: 23135062
-
Dental screening and referral of young children by pediatric primary care providers.Pediatrics. 2004 Nov;114(5):e642-52. doi: 10.1542/peds.2004-1269. Pediatrics. 2004. PMID: 15520094
-
Improving integration and coordination of funding, technical assistance, and reporting/data collection: recommendations from CDC and USAPI stakeholders.Pac Health Dialog. 2011 Mar;17(1):185-97. Pac Health Dialog. 2011. PMID: 23008984
-
Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.Clin Toxicol (Phila). 2008 Aug;46(7):661-76. doi: 10.1080/15563650802178136. Clin Toxicol (Phila). 2008. PMID: 18608263 Review.
-
Epidemiology.In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 9. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 9. PMID: 21413284 Free Books & Documents. Review.
Publication types
Grants and funding
This publication is part of the Substance Abuse Prevention and Treatment Block Grant technical assistance program. This publication was written under contract number ADM 270-90-0001 from the Center for Substance Abuse Treatment of the Substance Abuse and Mental Health Services Administration (SAMHSA). Richard Bast served as the Government project officer. Stuart M Berman, MD; Bernard Branson, MD, Beth A Dillon, MSW; Samuel W Dooley, Jr, MD; Dorothy C Gunter, MPH; Christopher H Hayden; Robert Johnson, MD, MPH; T Stephen Jones, MD; Bess Miller, MD, MSc; Louis B Polish, MD; William O Schalla, MS; George Schmid, MD; and Ronald O Valdiserri, MD, MPH, of the Centers for Disease Control and Prevention, served as technical experts. Text development was provided by Mollie Sayers, Patricia Kassebaum, and Dixie McGough.
LinkOut - more resources
Full Text Sources
